These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 18495128)
1. 3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE(-/-)/LDL(-/-) double knockout mice. Langheinrich AC; Sedding DG; Kampschulte M; Moritz R; Wilhelm J; Haberbosch WG; Ritman EL; Bohle RM Atherosclerosis; 2009 Jan; 202(1):103-10. PubMed ID: 18495128 [TBL] [Abstract][Full Text] [Related]
2. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice. Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):347-52. PubMed ID: 16293797 [TBL] [Abstract][Full Text] [Related]
3. Quantitative CT imaging of the spatio-temporal distribution patterns of vasa vasorum in aortas of apoE-/-/LDL-/- double knockout mice. Kampschulte M; Brinkmann A; Stieger P; Sedding DG; Dierkes C; Bohle RM; Krombach G; Ritman EL; Langheinrich AC Atherosclerosis; 2010 Oct; 212(2):444-50. PubMed ID: 20692662 [TBL] [Abstract][Full Text] [Related]
4. Vasa vasorum neovascularization and lesion distribution among different vascular beds in ApoE-/-/LDL-/- double knockout mice. Langheinrich AC; Michniewicz A; Bohle RM; Ritman EL Atherosclerosis; 2007 Mar; 191(1):73-81. PubMed ID: 16806224 [TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis, inflammation and lipoprotein glomerulopathy in kidneys of apoE-/-/LDL-/- double knockout mice. Langheinrich AC; Kampschulte M; Scheiter F; Dierkes C; Stieger P; Bohle RM; Weidner W BMC Nephrol; 2010 Aug; 11():18. PubMed ID: 20727187 [TBL] [Abstract][Full Text] [Related]
6. Thalidomide influences atherogenesis in aortas of ApoE(-/-)/LDLR (-/-) double knockout mice: a nano-CT study. Kampschulte M; Gunkel I; Stieger P; Sedding DG; Brinkmann A; Ritman EL; Krombach GA; Langheinrich AC Int J Cardiovasc Imaging; 2014 Apr; 30(4):795-802. PubMed ID: 24487918 [TBL] [Abstract][Full Text] [Related]
7. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. Gössl M; Versari D; Hildebrandt HA; Bajanowski T; Sangiorgi G; Erbel R; Ritman EL; Lerman LO; Lerman A JACC Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 20129528 [TBL] [Abstract][Full Text] [Related]
8. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice. Veerman KJ; Venegas-Pino DE; Shi Y; Khan MI; Gerstein HC; Werstuck GH Atherosclerosis; 2013 Apr; 227(2):250-8. PubMed ID: 23411040 [TBL] [Abstract][Full Text] [Related]
9. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice. Ma L; Ni M; Hao P; Lu H; Yang X; Xu X; Zhang C; Huang S; Zhao Y; Liu X; Zhang Y Oncotarget; 2016 Mar; 7(13):16194-204. PubMed ID: 26908443 [TBL] [Abstract][Full Text] [Related]
10. Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice. Tanaka K; Nagata D; Hirata Y; Tabata Y; Nagai R; Sata M Atherosclerosis; 2011 Apr; 215(2):366-73. PubMed ID: 21306712 [TBL] [Abstract][Full Text] [Related]
11. Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE Wang F; Chen FF; Shang YY; Li Y; Wang ZH; Han L; Li YH; Zhang L; Ti Y; Zhang W; Zhong M Int J Cardiol; 2018 Aug; 265():181-187. PubMed ID: 29685689 [TBL] [Abstract][Full Text] [Related]
12. Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Gössl M; Herrmann J; Tang H; Versari D; Galili O; Mannheim D; Rajkumar SV; Lerman LO; Lerman A Basic Res Cardiol; 2009 Nov; 104(6):695-706. PubMed ID: 19458984 [TBL] [Abstract][Full Text] [Related]
13. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model. Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418 [TBL] [Abstract][Full Text] [Related]
14. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia--implications for vulnerable plaque-development. Gössl M; Versari D; Mannheim D; Ritman EL; Lerman LO; Lerman A Atherosclerosis; 2007 Jun; 192(2):246-52. PubMed ID: 16919638 [TBL] [Abstract][Full Text] [Related]
15. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo. Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413 [TBL] [Abstract][Full Text] [Related]
16. Si-Miao-Yong-An on promoting the maturation of Vasa Vasorum and stabilizing atherosclerotic plaque in ApoE Qi Z; Li M; Zhu K; Zhang J Biomed Pharmacother; 2019 Jun; 114():108785. PubMed ID: 30909142 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-2 is required for vasa vasorum plexus stability in hypercholesterolemic mice. Mollmark JI; Park AJ; Kim J; Wang TZ; Katzenell S; Shipman SL; Zagorchev LG; Simons M; Mulligan-Kehoe MJ Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2644-51. PubMed ID: 22982464 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Moulton KS; Vakili K; Zurakowski D; Soliman M; Butterfield C; Sylvin E; Lo KM; Gillies S; Javaherian K; Folkman J Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4736-41. PubMed ID: 12682294 [TBL] [Abstract][Full Text] [Related]
19. Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Moulton KS; Olsen BR; Sonn S; Fukai N; Zurakowski D; Zeng X Circulation; 2004 Sep; 110(10):1330-6. PubMed ID: 15313955 [TBL] [Abstract][Full Text] [Related]
20. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice. Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]